期刊文献+

思瑞康与氯氮平各治疗20例精神分裂症患者社会功能改善的研究 被引量:1

A comparative study of social function in schizophrenia patients treated with seroquel(guetiapine) or clozapine
下载PDF
导出
摘要 目的:比较思瑞康(seroquel)与氯氮平(clozapine)治疗对改善精神分裂症患者社会功能的作用。方法:随机收集20例服用思瑞康、20例服用氯氮平的精神分裂症患者,用阳性症状和阴性症状量表(PANSS)、简明精神病评定量表(BPRS)、不良反应评定量表(TESS)分别评定,并在出院后半年用社会功能缺陷量表(SDSS)评定,同时与影响其某些因素进行相关分析及多元逐步回归分析。结果:半年后随访发现,服用思瑞康的精神分裂症患者在职业工作、婚姻职能、父母职能和社会退缩、责任心和计划方面明显好于氯氮平。多元逐步回归分析显示,影响社会功能的因素为不能积极参加组织活动、得到家庭支持和照顾少、经济损失多、不能与他人和睦相处、BPRS评分高者社会功能差,服用氯氮平的比思瑞康差。半年随访时思瑞康TESS评分较低,两组比较有显著性差异。结论:思瑞康与氯氮平相比不仅不良反应轻微,而且能很好的改善社会功能。 Objective:To compare the social function, in schizophrenic patients treated with seroquel or clozapine. Methods: Forty Patients with the diagnosis of schizoph were randomly entered into seroquel group( n = 20) and Clozapine. group (n = 20), The thera Peutic response and side effects were evaluated with the Positive and negative symptom scale(PANSS) and the treatment emergent symptom scale(TESS). All patients were assessed with the social disability screening schedule (SDSS) at the sixth month after discharge. Results : It was found that the social ( including profession, marriage, parental responsibility, etc) functions were significantly better in seroquel group than in clozapine group. With multiple regression analysis, the main associated. Factors of impaired social function were high impaired scores of BPRS, get family with the social help, bad personnel relation, ship and using clozapine. Conclusions: seroquel is superior clozapine to improve the condition, of social function, in schizophrenic patients.
出处 《中国民康医学》 2008年第11期1137-1137,1139,共2页 Medical Journal of Chinese People’s Health
关键词 精神分裂症 思瑞康 氯氮平 社会功能 Schizophrenia Seroquel Clozapine Social function
  • 相关文献

参考文献4

二级参考文献10

  • 1侯钢,袁廷干.精神分裂症患者听觉P300的异常变化[J].中华神经精神科杂志,1993,26(2):116-118. 被引量:11
  • 2[1]Small JG,Hirsh SR,Arvanitis LA,et al.Quetiapine in patients with schizophrenia:a high dose and low dose double-blind comparison with placebo.Arch Gen Psychiatry,1997,54:549
  • 31,Andersson C,Chakos M,MailmanR,et al.Emerging roles for novel antipsychotic medications in the treatment ofschizophtrnia.Psychiatr Clin North Am,1998,21:151
  • 43,Borison RL. The role of cognition in the risk-benefit and safety analysis ofantipsychotic medication.Acta Psychiatr Scand,1996,389(suppl):5
  • 54,Rossi A,Mancini F,Strata P,et al.Risperidone negative symptoms and cognitive deficitin schizophrenia:an open study.Acta Psychiatr Scand,1997,95:40
  • 65,Stip E,Lussier I.The effect of risperidone on cognition in patients withschizophrenia.Can J Psychiatry,1996,41(suppl 2):S35
  • 76,Gallhofer B,Bauer U,Lis S,et al.Cognitive dysfunction in schizophrenia:comparison oftreatment with atypical antipsychotic agents and conventional neuroleptic drugs.EurNeuropsychopharmacology,1996,6(suppl 2):S13
  • 8赵靖平,杨德森.精神分裂症认知功能的研究进展[J].中华精神科杂志,1998,31(1):58-59. 被引量:195
  • 9王传跃,向应强,翁永振,翟屹民,李文标,蔡焯基.精神分裂症患者氯氮平维持治疗的治疗依从性、剂量及浓度研究[J].中华精神科杂志,2001,34(3):138-141. 被引量:28
  • 10李文标,薛亚震,翟屹民,张军,郭桂欣,王传跃,蔡焯基.HPLC紫外检测法测定血清富马酸喹硫平浓度[J].药物分析杂志,2003,23(4):247-251. 被引量:6

共引文献56

同被引文献4

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部